Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H49N5O8 |
Molecular Weight | 571.7067 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCC(=O)N[C@@H](C)C(=O)N[C@H](CCC(=O)N[C@@H](CCC[C@H](N)C(N)=O)C(O)=O)C(O)=O
InChI
InChIKey=TUNXCNXMSJZNPO-XSDIEEQYSA-N
InChI=1S/C27H49N5O8/c1-3-4-5-6-7-8-9-10-11-15-22(33)30-18(2)25(36)32-21(27(39)40)16-17-23(34)31-20(26(37)38)14-12-13-19(28)24(29)35/h18-21H,3-17,28H2,1-2H3,(H2,29,35)(H,30,33)(H,31,34)(H,32,36)(H,37,38)(H,39,40)/t18-,19-,20-,21+/m0/s1
Molecular Formula | C27H49N5O8 |
Molecular Weight | 571.7067 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Tabilautide (also known as RP 56142) is a tripeptide derivative patented by Rhone-Poulenc Industries S. A. as an immune adjuvant. In preclinical studies, Tabilautide displays potent protective activities against bacterial infections such as K. pneumoniae, L. monocytogenes or S. Typhimurium. Besides that Tabilautide shows antimetastatic activity and induces macrophage activation and enhanced cytotoxicity of natural killer cells in spleen, blood, and liver. These activities correlate with prophylactic and therapeutic effects of Tabilautide on artificial liver metastases of histiocytosarcoma.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:35:19 GMT 2023
by
admin
on
Fri Dec 15 16:35:19 GMT 2023
|
Record UNII |
EZ61NB05TG
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C308
Created by
admin on Fri Dec 15 16:35:19 GMT 2023 , Edited by admin on Fri Dec 15 16:35:19 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Tabilautide
Created by
admin on Fri Dec 15 16:35:19 GMT 2023 , Edited by admin on Fri Dec 15 16:35:19 GMT 2023
|
PRIMARY | |||
|
6241
Created by
admin on Fri Dec 15 16:35:19 GMT 2023 , Edited by admin on Fri Dec 15 16:35:19 GMT 2023
|
PRIMARY | |||
|
EZ61NB05TG
Created by
admin on Fri Dec 15 16:35:19 GMT 2023 , Edited by admin on Fri Dec 15 16:35:19 GMT 2023
|
PRIMARY | |||
|
SUB10793MIG
Created by
admin on Fri Dec 15 16:35:19 GMT 2023 , Edited by admin on Fri Dec 15 16:35:19 GMT 2023
|
PRIMARY | |||
|
CHEMBL2375145
Created by
admin on Fri Dec 15 16:35:19 GMT 2023 , Edited by admin on Fri Dec 15 16:35:19 GMT 2023
|
PRIMARY | |||
|
DTXSID00228722
Created by
admin on Fri Dec 15 16:35:19 GMT 2023 , Edited by admin on Fri Dec 15 16:35:19 GMT 2023
|
PRIMARY | |||
|
3086083
Created by
admin on Fri Dec 15 16:35:19 GMT 2023 , Edited by admin on Fri Dec 15 16:35:19 GMT 2023
|
PRIMARY | |||
|
C76570
Created by
admin on Fri Dec 15 16:35:19 GMT 2023 , Edited by admin on Fri Dec 15 16:35:19 GMT 2023
|
PRIMARY | |||
|
78088-46-7
Created by
admin on Fri Dec 15 16:35:19 GMT 2023 , Edited by admin on Fri Dec 15 16:35:19 GMT 2023
|
PRIMARY | |||
|
100000082992
Created by
admin on Fri Dec 15 16:35:19 GMT 2023 , Edited by admin on Fri Dec 15 16:35:19 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |